Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news—or the bad—from your shop, and we will feature it here at the end of each week.
Week of Dec. 15
Charlene MacDonald has been named as the next president and CEO of the Federation of American Hospitals, effective Jan. 1, 2026.
MacDonald has been with the for-profit hospital lobbying group for the past two years as its executive vice president of public affairs, where she headed advocacy and government affairs while overseeing finance and operations.
Ahead of that she held roles as chief government affairs officer at CareFirst BlueCross BlueShield, and the head of healthcare and life sciences within the strategic communications segment of FTI Consulting. Further, she held senior policy positions on Capitol Hill within the House and the Senate.
“The Board has full confidence in Charlene MacDonald to champion tax-paying hospitals and their patients, advance pragmatic solutions to our most pressing policy challenges and lead the Federation into the future,” Marc D. Miller, Federation of American Hospitals board chair as well as the president and CEO of Universal Health Services, said in the announcement. “Charlene brings the right combination of experience, expertise, vision, and commitment to our mission of improving patients’ access to quality healthcare.”
MacDonald succeeds Charles "Chip" Kahn III, who has held the Federation of American Hospitals' top roles since 2001 and carved a similar path through Congress to lead the organization. He had announced plans to retire in June.
Jim Rechtin, CEO of Humana, has been named chair of the board for AHIP, the insurance industry's largest lobbying organization.
Rechtin will take on the chair role beginning Jan. 1, succeeding Pat Geraghty, who is retiring from GuideWell and Florida Blue at the end of this year. In the announcement, Rechtin said he was heavily involved in the insurance industry's pledge earlier this year to ease prior authorization, saying the effort "shows what’s possible when health plans work together to deliver for patients."
"As board chair, I look forward to taking the same cooperative approach to helping health consumers navigate the system and access high-quality, affordable care,” Rechtin said.
AHIP said it also added two new board members: Patrick Gilligan, President and CEO of Point32Health, and Brian Pieninck, President and CEO of GuideWell and Florida Blue.
Week of Dec. 8
Community Health Systems has decided to make interim CEO Kevin Hammons and interim Chief Financial Officer Jason Johnson its permanent choices for those two roles, which they've served in since Oct. 1. Hammons has also been appointed to serve as a member of the hospital chain's board of directors.
Hammons joined CHS in 1997 and had been CHS' chief financial officer since January 2020, stepping up into the interim CEO role after the announced retirement of Tim Hingtgen. Johnson has been with the organization since 2012 and had served as chief accounting officer since 2019.
Rick Pollack, longtime president and CEO of the American Hospital Association, announced plans to retire by the end of 2026. The lobbying group's board has launched a national search for his successor.
Pollack has spent 43 years at the AHA, including the last decade at its helm, according to the announcement. He played a critical role in leading the hospital industry through the COVID-19 pandemic, including efforts to secure key flexibilities and financial support from regulators during the public health crisis. Read more.
Steve Purves, president and CEO of Valleywise Health, a public teaching health system serving the Phoenix, Arizona area, will retire with the end of his current contract in October 2026.
Purves has led a 45-year career in healthcare administration and been with Valleywise for 12 years. The organization, in its announcement, credited Purves for leading a financial turnaround that "delivered more than $170 million in fiscal improvements and stabilized the organization’s future."
Week of Dec. 1
Martin Kulldorff, Ph.D., has been appointed chief science officer for the Department of Health and Human Services' (HHS') Office for the Assistant Secretary for Planning and Evaluation (ASPE), according to a Dec. 1 announcement.
ASPE is the health department's "in-house think tank" with input on policies and analyses related to healthcare and public health, per the announcement.
Kulldorf, a biostatistician and epidemiologist, was a professor at Harvard until last year. He is a well-known critic of COVID-19 vaccination requirements and pandemic-era restrictions, and was among the coauthors of the Great Barrington Declaration that in 2020 called on public health to embrace a herd immunity strategy.
Earlier this year he had been appointed as the chair of the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP), following HHS Secretary Robert F. Kennedy's controversial overhaul of the vaccine advisory group. Public health groups have criticized the move for replacing established experts with advisors who share the secretary's skepticism on childhood vaccine safety. Meetings held this year under Kulldorf have debated the agency's stance on COVID-19 vaccines and at-birth hepatitis B shots.
"Martin Kulldorff transformed ACIP from a rubber stamp into a committee that delivers gold-standard science for the American people," Kennedy said in the announcement. "I'm glad to welcome him to my team to help develop bold, evidence-based policies to Make America Healthy Again."
With Kulldorff's move, the ACIP's chair now goes to Kirk Milhoan, M.D., Ph.D., a pediatric cardiologist and former U.S. Air Force flight surgeon who had been appointed to the committee in September and has attributed an increase in cardiovascular disease to vaccines. ACIP is scheduled to meet again later this week, with newborn hepatitis B shots again on the agenda for discussion.
Monday's personnel changes also come a week after news that Ralph Abraham, M.D., had been quietly named depute director of the CDC. A former U.S. House representative and surgeon general for Louisiana, he has been similarly critical of COVID-19 vaccines and, earlier this year, restricted Louisiana's state public health workers to stop promoting seasonal vaccines.
Week of Nov. 17
Former Deputy Commissioner of the Food and Drug Administration Deb Autor has joined direct-to-consumer telehealth platform Hims & Hers as its first Chief Policy Officer. Autor helped lead the FDA during the Obama administration, and she was formerly a prosecutor for the Department of Justice.
Since leaving the federal government, Autor has led global regulatory policy for Mylan and AstraZeneca, served on the boards of US Pharmacopeia, Amneal Phamaceuticals, Pardes Biosciences and AMR Industry Alliance.
She joined the board of Hims & Hers in 2024. Now, Autor will work directly with policymakers and regulators on behalf of the telehealth company, which has been in hot water with the federal government this year for online advertising of its weight loss drugs.
“Extraordinary innovation in areas such as AI, robotics, and at-home diagnostics provides an opportunity to reshape how we deliver access to healthcare,” Autor said in a statement. “Now is the time to harness new technologies to make care more proactive, personal, and accessible. Hims & Hers is setting a new standard for what responsible progress in healthcare looks like, and I’m excited to help shape the policies that will make that future a reality.”
“As digital health continues to evolve, the policies we shape today will define access, safety, and innovation for years to come,” Andrew Dudum, CEO and co-founder of Hims & Hers, said. “Deb’s unparalleled regulatory experience and forward-looking vision make her the ideal leader to guide our engagement with stakeholders at this pivotal moment.”
Week of Nov. 10
> The American Telemedicine Association announced that CEO Ann Mond Johnson is set to retire, effective Dec. 10.
The organization's board of directors has named Kyle Zebley, senior vice president for public policy at the ATA and executive director of ATA Action, as Mond Johnson's successor, according to an announcement. ATA said that Zebley will continue as director of ATA Action when he takes the CEO chair.
The shift is part of a planned leadership change that ATA said is "designed to ensure continuity and the ongoing success of the organization," per the press release.
“Ann Mond Johnson is a driven and energetic advocate for using digital health technologies to increase healthcare access, especially among those who most desperately need quality care, establishing telehealth as an essential modality of delivering care where and when it’s needed," said Nathaniel Lacktman, chair of the Telemedicine and Digital Health Industry Team at Foley & Lardner LLP and chair of the ATA Board of Directors, in the announcement.
"Her legacy at the ATA will continue to guide our work to help modernize healthcare delivery," Lacktman said.
Mond Johnson joined the organization in 2018 as its CEO and steered the ATA through the COVID-19 pandemic. Zebley, meanwhile, joined ATA in July 2020 and under his leadership, the organization has grown its policy and advocacy work.
Mond Johnson and Zebley worked together to launch ATA Action, per the announcement.
“Kyle Zebley and I have worked closely together for over five years, and I have utmost confidence in his leadership," Mond Johnson said.
Week of Nov. 3
> The Cigna Group has named Amy Flaster, M.D., as its chief medical officer.
Flaster previously joined the company as CMO at its Cigna Healthcare insurance division. Her appointment to CMO at the broader corporation took effect on Nov. 1, according to the announcement.
In the role, she will lead the charge on driving clinical excellence, developing new care models and deploying technology to address whole-person health at both Cigna and Evernorth. In her time so far at Cigna, she has already spearheaded key clinical programs that improved patient outcomes as well as generated savings for clients and plan sponsors, the company said.
As Cigna Group CMO, Flaster will report to Chief Operating Officer Brian Evanko.
"Dr. Flaster is a proven strategic and innovative leader with extensive clinical and operational experience in patient care, technology, hospital leadership and value-based care," said Dave Cordani, CEO of the Cigna Group, in the announcement. "In this new role, she will continue our journey to improve the health of millions of patients in partnership with their clinicians."
Prior to joining Cigna, Flaster was CMO at ConcertoCare and also held leadership positions at Mass General Brigham.
Alongside the news of Flaster's promotion, Cigna announced that Chief Health Officer David Brailer, M.D., will depart the company. He has held the role since 2022, and additional details about his departure were not disclosed.
Cigna also revealed that Katya Andresen, the company's chief digital and analytics officer, will take over leadership of the company's excellence and transformation efforts. Chris DeRosa, head of business improvement and innovation, will retire after spending more than two decades at the company.
Week of Oct. 20
> Steven Corwin, M.D., will be stepping down from his dual roles of president and CEO of NewYork-Presbyterian on Jan. 22, 2026, with current Executive Vice President and Chief Operating Officer Brian Donley, M.D., selected as his successor.
Corwin has held the top role for 14 years, and has been a member of NewYork-Presbyterian's management team since 1991. His tenure saw the organization double in size from five hospitals to 10, plus nearly 200 clinics and medical groups and more than 40,000 employees. He also led the organization through the COVID-19 pandemic.
Donley came to NewYork-Presbyterian in 2023, having previously spent about 17 years at Cleveland Clinic first as an orthopedic surgeon and later as the CEO of Cleveland Clinic London. He's spent the past couple of years focused on operational efficiency and strategic growth planning for NewYork-Presbyterian.
"I understand the long history of NewYork-Presbyterian’s impact on our city and our country, and I am committed to enhancing that impact and building on Steve’s remarkable legacy of delivering world-class care and improving the health of our communities," Donley said in the announcement.
> Mala Murthy, the chief financial officer at telehealth giant Teladoc Health, plans to leave the company to pursue an opportunity outside of the healthcare industry, the company announced Thursday. Murthy, who joined the company in June 2019, will serve in her role until Nov. 21.
Teladoc has initiated a search process to find its next CFO. While the search is completed, an interim leadership structure will be in place with key finance leaders reporting to Teladoc Health Chief Executive Officer Chuck Divita, the company said.
“It has been a privilege to serve as Teladoc Health’s Chief Financial Officer during a pivotal time in virtual care,” Murthy said in a statement. “I’m deeply grateful for the opportunity to have worked with such an exceptional, committed team.”
"As CFO, Mala made significant contributions to the company, building financial strength and advancing strategic priorities to support our market leadership position. I want to personally thank Mala for her partnership and wish her well in her next role," Divita said.
> Alicia Jackson was sworn in Monday as the new director of the Advanced Research Projects Agency for Health (ARPA-H), an agency within the Department of Health and Human Services tasked with bridging the gap between public and private health innovation.
Jackson is an MIT-trained materials scientist who spent five years at the Defense Department's Defense Advanced Research Projects Agency (DARPA), upon which ARPA-H is loosely modeled, first as a program manager and later as the deputy director of its Biotechnology Office. During that tenure she guided investment portfolios spanning biodefense, medicine development and biomanufacturing.
From there she went on to cofound Drawbridge Health, an at-home blood sampling device company, and is currently the founder and CEO of menopause and perimenopause virtual health platform Evernow. The latter provides one-time and ongoing telehealth appointments and connects users to prescription medications, labs and wellness products.
Week of Sept. 29
> Tim Hingtgen, director and CEO of Community Health Systems, retired from his posts on Sept. 30 and on Oct. 1 entered an agreement to provide consulting services to the for-profit health system's management team, according to a regulatory filing.
The change was announced earlier this year with the company's second quarter earnings, with president and chief financial officer Kevin Hammons stepping up as interim CEO.
Hingtgen had been with the company for 18 years and CEO for four and a half years. He had said in July's announcement that he decided to step down “for personal reasons, including a desire to spend more time with my family and to pursue a few dreams I have for my life.”
As a consultant, Hingtgen will be receiving fees of $33,333.33 per month from his Community Health Systems, according to the filing.
> Robert Ritz is retiring from his post as president and CEO of MercyOne effective Jan. 2, 2026, closing out four decades of healthcare leadership.
He'd joined the West Des Moines, Iowa-based system in 2013 as president of Mercy Des Moines Hospital. He was appointed CEO of Mercy Health Network in 2017, which at that time was co-owned by CommonSpirit Health and Trinity Health.
The system was rebranded as MercyOne in 2019 and, in 2022, fully acquired by Trinity Health. Just a year later Trinity would close an acquisition of Genesis Health System, which fell under Ritz' preview as MercyOne Genesis.
Amid the transactions and other expansions under Raitz' watch, MercyOne grew to a system of 22,000 employees, 40 owned and affiliated hospitals and more than 4 million patient visits per year.
Trinity Health said it will begin recruiting for Ritz's successor "in the coming months."
> Paul Haut, M.D., will become president of the Children's Hospital Association (CHA) on Oct. 14.
The pediatric oncologist will tackling the organization's education and programming around topics like quality and patient safety, data analytics and finance. He'll also join CHA CEO Matthew Cook to work on the association's strategic direction and priorities, as well as its fiscal health and other objectives.
Haut spent 20 years at Indiana's Riley Children's Health, where he eventually served as chief medical officer and chief operating officer. Following that, he was an associate professor of pediatrics at IU School of Medicine and opened a leadership coaching firm, PRHaut Leadership.
“Paul’s diverse background as a pediatrician directing stem cell transplants, a medical professor, and as a hospital executive mean he is particularly suited to support CHA’s member hospitals,” Cook said in the announcement. “Paul’s breadth of knowledge and deep understanding of the challenges our hospitals face are invaluable to our work at CHA, and we look forward to growing the association with his support.”
Week of Sept. 8
> Mike Hulefeld, president and chief operating officer of Ochsner Health, will depart the position at the end of the year.
The health system announced that Timothy Riddell, M.D., will succeed Hulefeld when he steps down. Hulefeld has spent 27 years at New Orleans-based Ochsner, including 13 as COO, per the announcement. He previously served as the CEO of Ochsner Medical Center in New Orleans for four years.
The health system said Hulefeld joined the team as an administrative fellow before moving up the ranks over the years.
"We are profoundly grateful to Mike for more than 25 years of dedicated leadership at Ochsner Health," said CEO Pete November. "During his remarkable time at Ochsner, he has set a standard of excellence and care that has shaped who we are as an organization."
After stepping down, Hulefeld will continue to be involved with Ochsner in mentoring young leaders, according to the announcement.
Riddell, meanwhile, has overseen Ochsner's central Mississippi and eastern Alabama hospitals since Jan. 1. He has been a member of the system's medical group for 28 years.
> CVS Health unveiled several leadership changes at the top of its care delivery division.
Sree Chaguturu, M.D., president of care delivery at CVS, said in a post on LinkedIn that Signify Health President Paymon Farazi will depart the company. Marcus Lanznar, senior vice president of product at Signify, will succeed Farazi.
Chaguturu said in the post that Lanznar is "well-prepared to lead Signify Health into its next era of growth and excellence."
In addition, Chaguturu said that Jon Thiboutot would step into the role of president for retail heath. He previously held leadership roles at MinuteClinic and in the healthcare giant's chronic care management team. Creagh Milford previously was both president of retail health and president of Oak Street Health in a dual role.
Chaguturu said that Thiboutot first joined CVS as a pharmacist more than two decades ago, and has played a pivotal role in MinuteClinic's growth and evolution.
> Craig Albanese, M.D., CEO of Duke University Health System, will depart to join the team at Kaiser Permanente, per an announcement.
Albanese will join the healthcare giant as president of integrated care and coverage on Sept. 29. In the role, he will "lead day-to-day operations for the integrated health care system," according to the announcement. He will report to directly to CEO Greg Adams.
Before becoming CEO at Duke, Albanese served multiple leadership roles in the health system, including chief operating officer. He also held leadership positions at NewYork-Presbyterian, including as chief clinical integration officer during a time of significant growth for the provider.
Albanese is also a pediatric surgeon.
"Craig has a deep commitment to high-quality care delivery and is an advocate for value-based care," Adams said in the release. "His strong leadership and deep operations and clinical experience, gained across multiple health systems, will help further strengthen Kaiser Permanente's operations, ensuring we can continue to meet the needs of our members and patients."
Week of Sept. 1
> America's Essential Hospitals announced Jennifer DeCubellis as next in line for the lobbying group's president and CEO roles.
The former health system CEO takes the reins from current head Bruce Siegel, M.D., on Sept. 22. Siegel, who has headed America's Essential Hospitals since 2010 and announced his retirement plans near the top of 2025, will stay on through the end of the year to ensure a smooth handoff.
DeCubellis spent the past five years as the CEO of Minneapolis-based Hennepin Healthcare System, a $1.6 billion, publicly owned integrated system, and prior to that was deputy county administrator for Hennepin County.
Her new role will give her an advocacy role for the organization's membership, which is made of more than 350 hospital groups serving an outsized share of uninsured or government-insured patients.
"Essential hospitals are under severe pressure, facing a host of unprecedented challenges, from funding shortfalls to staffing challenges. Jennifer will be a critical voice in Washington representing the interests of our members and the communities they serve,” said Thomas J. Quatroche Jr., chair of the group's board as well as the CEO of Erie County Medical Center.
Week of August 25
> Aegis Ventures hired former Walgreens executive John Driscoll and Cris Ross, former CIO at Mayo Clinic, as venture partners. Aegis is a NYC-based venture studio that partners with entrepreneurs and health systems to launch and scale meaningful healthtech startups that drive healthcare forward. Driscoll, a veteran entrepreneur and operator, has led organizations including Walgreens Boots Alliance, Castlight Health, Medco, CareCentrix, and Surescripts. Ross spearheaded Mayo Clinic's digital transformation and held senior technology roles at CVS Health and Optum.
As venture partners, they will help Aegis surface and evaluate opportunities for new company creation and advise portfolio companies on commercialization, integration with health systems, and strategic partnerships, the venture studio said.
> OpenAI is growing its healthcare leadership team, signaling that the AI company has big ambitions for the healthcare market. Ashley Alexander, who previously led the Instagram product team, joined as the company's new vice president of health products. She spent 12 years working on Instagram at Meta. At OpenAI, she will build tech for individual consumers and clinicians, Business Insider reported.
"Since I was in college almost two decades ago studying Healthcare Management, I have wanted to improve healthcare outcomes and access. This passion runs deep personally for me, having supported both of my parents through two different cancers each and having had my own encounters with the healthcare system as a birthing mother of two. With the way technology is advancing right now, I feel for the first time my skill set has the potential to really bend the curve on healthcare quality and access," she wrote in a LinkedIn post this week.
Nate Gross, M.D., formerly co-founder and chief strategy officer at Doximity, jumped on board at OpenAI back in June to lead the company's go-to-market strategy in healthcare, Business Insider reported.
> Availity, a real-time health information network, tapped Tim Bergeson as the company’s new Chief Revenue Officer. He will lead Availity’s revenue and sales organization, aligning teams across the enterprise to accelerate growth, strengthen customer partnerships, and advance the company’s mission to simplify healthcare through innovation and trusted collaboration.
Week of Aug. 18
> Kaiser Permanente tapped Jeff Krawcek, M.D. to serve as executive vice president and chief executive officer for the KP Medical Foundation. He is the current president and executive medical director of the Colorado Permanente Medical Group. In the new role, Krawcek will work in close coordination with participating Permanente Medical Groups to support ambulatory care performance across access, quality, service, and total cost of care. This includes overseeing the foundation’s functions in service to Colorado and Washington medical groups. He will also drive collaboration and foster sharing and adoption of best practices across markets and medical groups to advance evidence-based care and medical excellence, including through the value-based platform.
Week of Aug. 4
> Independence Health Group has named Kelly Munson as its president and CEO, effective Oct. 1.
Munson will succeed current CEO Gregory Deavens, who announced plans to retire in January. Deavens has held the CEO chair since 2021.
Munson is currently the president and CEO of AmeriHealth Caritas, one of Independence's subsidiaries. She was chosen to lead the full company after a national search, according to a company announcement, and will continue to serve in a key oversight role at AmeriHealth Caritas after shifting roles.
She took the helm of AmeriHealth Caritas in February 2024 after leading the Medicaid unit of CVS Health's Aetna. She has 25 years of healthcare leadership under her belt that also includes time at WellCare Health Plans.
“Kelly has already made substantial contributions to Independence Health Group, and I am thrilled that she will succeed me as President and CEO,” Deavens said in the announcement. “She is an innovative and collaborative leader, and her expertise in business operations is perfectly complemented by her unwavering dedication to our mission. Kelly will continue to empower and uplift our communities, and advocate for affordable, accessible, and equitable health care for all the members we serve.”
> In more Blues leadership news, GuideWell—the parent company of Florida Blue—has named Brian D. Pieninck as its new CEO. Pieninck will take the helm on Oct. 1.
He will follow Pat Geraghty, who announced in March that he will retire from the company after 14 years. Pieninck currently serves as president and CEO of CareFirst Blue Cross Blue Shield, and is a chair of the Blue Cross Blue Shield Association's Board of Directors.
Pieninck has been at CareFirst since 2015 in different leadership roles, and previously served as an executive at Aetna for 19 years, according to an announcement.
“I am deeply proud of our team and what we have accomplished,” Geraghty said in the release. “It is my pleasure to turn the reins over to Brian Pieninck, someone I have known and worked with on the BCBSA Board and for whom I have great admiration.”
Geraghty has overseen significant growth at Florida Blue and later GuideWell, as the company expanded from an $8 billion health plan to a $32 billion enterpriss.
> Vanessa Colella has been tapped as president and CEO of Stellarus, a health tech company that's a sister to Blue Shield of California.
Colella is a global leader in the financial services market, according to an announcement, leading the development of key digital products and services for Visa, serving as global head of innovation and digital partnerships. She also held leadership roles at Citi.
Stellarus partners with insurers to drive administrative and medical cost savings through its proprietary tech stack. The company was formed when Blue Shield unveiled its new holding company Ascendiun earlier this year.
"I am thrilled to work with the Stellarus team as we reimagine how advanced technologies and artificial intelligence can be applied to help health plans and members move forward with affordable and effective care," Colella said in the announcement. "Expect some big and exciting news from Stellarus in the coming months."
Week of July 7
> Ketul J. Patel has been tapped as the next president and CEO of Wellstar Health System. He is succeeding Candice L. Saunders, who in January had announced plans to retire after holding the roles for a about a decade.
Patel comes from CommonSpirit Health, where he serves as president of its Pacific Northwest Region and the CEO of its Virginia Mason Franciscan Health. That post has him in charge of 12 hospitals, over 300 care locations and 20,000 employees.
Georgia's Wellstar comprises 11 hospitals and roughly 450 other locations. Patel is expected to join the organization in late October after the system's Board of Trustees confirms the selection later this month.
Liz Dunne, president and CEO of Vancouver, Washington-based nonprofit health system PeaceHealth, announced plans to retire after 10 years with the organization. Her tenure was marked by high hospital quality ratings, recorded charitable contribution fundraising and care expansions via strategic partnerships and acquisitions.
The nine-hospital system's board has unanimously appointed Sarah Ness, its current executive vice president and chief administrative officer, as Dunne's successor, effective Jan. 3, 2026. Ness has been at PeaceHealth for more than 20 years and is credited with leading organizational transformations within the system's culture, technology systems and operations.
> The Blue Cross Blue Shield Association is welcoming back former executive Sean Robbins, who will step into the role of executive vice president of business operations.
In this position, Robbins will oversee BCBSA's work in the Federal Employee Program, which offers coverage to 5.7 million federal workers, retirees and their families. The market solutions team, which develops national solutions across different types of coverage, will also fall under Robbins' umbrella, according to an announcement from BCBSA.
“Sean brings strong business acumen spanning health plan operations, market strategy, and public policy, and his leadership will be critical as we advance solutions that address shared challenges,” said Kim Keck, BCBSA’s president and CEO. “Sean also has a personal understanding of the Blues' superpower of being deeply rooted in their communities and will work with BCBS plans to advance and amplify Blue System efforts for collective success.”
Robbins previously served as BCBSA's chief corporate affairs officer, and has also held leadership roles at multiple Blues insurers, including president of Regence Blue Shield of Idaho.
Week of June 9
> Women's health provider Wisp appointed Jennifer Peña, M.D., as the company’s chief medical officer. Peña will have a crucial role in driving Wisp’s commitment to being the one-stop-shop for all women’s health needs, as the company continues to scale new and existing offerings, company executives said.
As CMO, Peña will spearhead Wisp’s clinical strategy, quality and safety programs, aligning telehealth operations with the company’s broader business goals. She will oversee clinical care delivery, ensuring regulatory compliance and high standards of patient care, while guiding product development and expanding protocols for new verticals.
She also will mentor and grow a multidisciplinary clinical team, establish KPIs to benchmark performance, and collaborate cross-functionally to integrate clinical insight into Wisp’s innovation and execution.
Peña has 20 years of clinical and leadership experience. As a board-certified internal medicine physician, she previously served as Medical Director for Oscar Health and Chief Medical Officer for Nurx, K Health, and Vault Health. Before that, she served as a U.S. Army physician and White House physician. She earned her MD from the University of Pittsburgh School of Medicine and her undergraduate degree from Yale University.
> Kindbody, a national fertility clinic network and global family-building benefits provider for employers, named David Stern as its new CEO to take the company into its next stage of growth.
Kindbody serves patients at 27 clinics and IVF labs, 400+ partner clinics, and in 113 countries around the world.
Stern brings to Kindbody more than three decades of experience in the fertility and women's healthcare industry. Prior to Kindbody, Stern served as Chief Executive Officer of Boston IVF for five years. He also served as CEO of Symbiomix Therapeutics. He also held senior executive roles at Merck Serono, where he served as Senior Vice President and Head of the Global Fertility Business Franchise, and at EMD Serono as Executive Vice President of Endocrinology within their biopharmaceutical division. His experience further includes strategic leadership at Celmatix, Ohana, and OvaScience.
Week of June 2
>Federation of American Hospitals (FAH) President and CEO Charles "Chip" Kahn III is retiring from the for-profit hospital lobbying group at the end of this year.
Kahn has served in FAH's top roles since 2001, and has been a mainstay in healthcare policy for almost 50 years.
He supported high-profile Republicans from the 1970s through the 1990s, initially as a campaign manager for former House Speaker Newt Gingrich and later as health aide to Sens. Dan Quayle and David Durenberger, plus other roles supporting Republican health legislature.
Prior to his work representing hospitals, Kahn held various leadership posts at the Health Insurance Association of America (now America's Health Insurance Plans), including president, where he was best known for overseeing the influential "Harry and Louise" political advertising campaign during the Clinton administration. He's also led or participated in several private and public healthcare quality initiatives such as the National Quality Forum and the Hospital Quality Alliance.
FAH said it has tapped organizational consulting firm Korn Ferry to search for Kahn's successor. Kahn, in a statement, hinted that he won't be fully stepping away from the world of healthcare policy.
“What an honor to have an opportunity for a quarter century—and during a consequential period of health policy making—to be the play caller for this important hospital sector. Much has been accomplished,” Kahn said. “Now it is time for a career turn to work on policy from another vantage point. I look forward to engaging in efforts to foster health care affordability, coverage, and quality improvement.”
Week of May 26
>Wolters Kluwer has appointed Greg Samios as CEO of its Health Division, effective June 1. Samios has served as executive vice president of the health division’s two largest business units, Clinical Effectiveness and Health Learning, Research, and Practice. Samios led the introduction of generative AI into the company and has grown its clinical decision support and clinical drug information products, UpToDate and Medi-Span.
Samios succeeds Stacey Caywood as CEO of the Health Division. Caywood is now a member of the executive board of Wolters Kluwer, effective May 15.
Week of May 19
>CVS Health looked within to find a new leader for its Oak Street Health division.
The healthcare giant has tapped Creagh Milford to serve as the president of Oak Street. Milford previously held the title of president of retail health at the company, leading its MinuteClinic work and other retail health initiatives.
In a post on LinkedIn, Milford said that he will continue to serve as interim president of retail health in the immediacy. He said that he will have time this week to meet with more members of the Oak Street team to discuss the future of the division.
"I’m excited to start a new chapter at CVS Health as President of Oak Street Health, where I have the honor of developing and executing business strategy to further grow the organization," Milford wrote in the post. "As a practicing physician, I am passionate about providing consumer-centric primary care to patients — and Oak Street Health shares that passion, resulting in better experiences and outcomes for the older adults we serve."
Week of May 5
>Hims & Hers announced Nader Kabbani as the direct-to-consumer health and wellness brand's new chief operations officer.
Kabbani comes by way of Amazon, where a nearly 20-year stint placed him in charge of PillPack's acquisition, the launch of Amazon Pharmacy and the company's global COVID-19 Vaccinations Task Force. He is expected to help Hims & Hers scale its operations globally.
>The American Telemedicine Association named Nathaniel Lacktman as the new chair of its board of directors. Lacktman is a partner at law firm Foley & Lardner and chairs its telemedicine and digital health industry team.
>Children's Minnesota has named Aimee Szewajs, M.D. as clinical vice president of specialty pediatrics. She takes over amid the planned retirement of Susan Sencer, M.D., from the same role.
Week of April 28
>SCAN Group has tapped several new leaders it says will play key roles in driving its clinical and digital innovation strategies forward.
Joe Kimura, M.D., will step into the role of chief medical officer for SCAN. Kimura brings key experience in population health, digital platforms and evidence-based medicine to the role, and previously served as CMO at Somatus and Atrius Health.
At SCAN, he will be tasked with leading the charge around new care models and ensuring its members have access to high-quality and high-value care.
The not-for-profit company also announced Vinay Kulkarni as its new chief information officer. He will lead the team's push into automation, cloud enablement and other IT operations. Before coming to SCAN, he held digital health leadership roles at Elevance Health, CareMore Health and Heritage Provider Network.
And finally, Zachary Myers will become national general manager, playing a lead role in managing the growth and performance of SCAN's Medicare Advantage plans. Within SCAN, he previously served as vice president of strategy and CEO of Welcome Health.
"As SCAN continues to push the boundaries of our clinical work and expands its footprint across the country to support the health and independence of our members, I am incredibly proud of the talent and vision of our leaders," said Sachin Jain, M.D., CEO of SCAN Group, in the announcement. "Their vision enables SCAN to set the standard in Medicare Advantage and transform the way we care for older adults."
Week of April 21
>UNC Health CEO and UNC School of Medicine Dean Wesley Burks, M.D., will be stepping away from his roles at the university on Sept. 1.
Burks has held those positions since late 2018, and before them had served as the School of Medicine's executive dean and chair of the Department of Pediatrics. He was also the physician-in-chief of UNC Children's Hospital.
Burks chose to step down to spend more time with his family and care for a family member's "increasing health needs," according to the announcement. He also plans to give more attention to the development of North Carolina Children's, a new nonprofit system announced earlier this year by UNC Health and Duke Health that will include North Carolina's first freestanding pediatric hospital.
The academic system's announcement pointed to his work guiding UNC Health through the addition of multiple hospitals, network providers and partnerships during his tenure. Burks' CV also includes clinical studies on food allergies.
Cristy Page, M.D., president of UNC Health Enterprises and the university's chief academic officer, will be serving as interim CEO and dean as the organization searches for Burks' successor.
>Veradigm, a healthcare data and tech company formerly known as Allscripts, will be losing Tom Langan, interim CEO, president and chief commercial officer, on July 31, according to a Securities and Exchange Commission 8-K filing.
The company's separation agreement with Langan will see him receive a full year's base salary, $1.4 million, plus his $406,000 target annual bonus and other benefits related to healthcare coverage and stock.
Langan has been with Veradigm since late 2018 but took up the interim CEO role on June 7, 2024 from another interim head, Shih-Yin Ho, M.D., who herself had stepped up after the company's board urged its prior leadership to resign amid auditing investigations.
The filing did not outline why Langan is leaving, but noted that he declined an invitation from the board to participate as a candidate in the ongoing search for a permanent CEO.
>Morgan Cheatham, M.D., has been tapped as a new Partner and Head of Healthcare and Life Sciences at Breyer Capital. Cheatham will work to invest in early stage healthcare companies including incubation and pre-seed through Series B investments.
He formerly worked at Bessemer Venture Partners, where he held a vice president role and was the youngest member of the Board of Directors. At Bessemer, Cheatham helped make early investments in health tech companies Abridge and Hinge Health, now multi-billion dollar companies.
When asked about his investing thesis, Cheatham said that he's keeping a close watch on companies that leverage innovative payment models.
“We feel like we're at this moment in healthcare and life sciences, where the science and the AI and the technological transformation is no longer the bottleneck," Cheatham said. "The bottleneck is the business model. It's the payment model, it's the economic model that underlies it. So that's a key area of focus for us as we think about making new investments.”
At Breyer Capital, Cheatham will oversee existing heathcare portfolio companies, Artera AI, Arena Bioworx, Open Evidence and Atropos Health, among others. He is also the first member of the firm that is not a part of the Breyer family. Founder Jim Breyer was the first investor in Facebook (Meta) and has been a part of more than 40 exits, including Spotify, Etsy, Marvel Entertainment, Legendary Pictures, and more.
Cheatham is also interested in pairing unmet clinical needs with the right modality to address the problem.
“Where are the unmet clinical needs, and how do we marry the right modality for that problem, whether it's a therapeutic, diagnostic software or a service or some amalgamation of those different tools that we have?” Cheatham said. “So we're really going on championing this notion of problem-specific, modality-agnostic investing.”
Cheatham said he’s interested in investing in what he calls “AI-first” companies, which often have AI researchers and scientists in house. He said companies that are building their own technology from scratch are constantly trying to push the state of the art and have a higher ceiling than companies that deploy others’ technology.
Week of April 14
>Insurtech Alignment Healthcare has accepted the resignation of Hakan Kardes, the company's chief experience officer, an 8-K filing shows. He will remain at the company through May 16, where he will then "pursue other professional opportunities."
He will be replaced by Aly Duzich, an internal promotion who previously served as senior vice president of clinical operations and population health. Before Alignment, Duzich spent six years at CareMore Health Plan, now known as Carelon Health, and seven years at SCAN Health Plan.
Alignment also named Arta Bakshandeh, M.D., as president of AVA, the company's Medicare Advantage platform. Bakshandeh was chief medical informatics officer since 2018.
>Crozer Health CEO Tony Esposito will be stepping down from his role at the end of the week, the Philadelphia Inquirer first reported citing an internal email sent Monday evening.
The Pennsylvania health system has been on the brink of closure for months amid parent company Prospect Medical Holdings' bankruptcy proceedings. Esposito has been with Crozer for over five years, and stepped into the CEO role in 2022. Taking over on an interim basis will be Greg Williams, president of Prospect's East Coast operations.
>Mayo Clinic has hired on Micky Tripathi, formerly the assistant secretary for technology policy and the national coordinator for health information technology under the Biden administration, as its new chief AI implementation officer, a representative of the system confirmed.
Tripathi is expected to begin next month, and will reportedly develop oversight and monitoring policies for the nonprofit as it applies AI across its organization. The task is in line with his accomplishments as a government official, where he helped develop an agenda for regulating AI development, training and use in healthcare.
>Mark Cuban Cost Plus Drug Company has named Erin Albert chief of pharmacy relations, network and privacy, according to a post on LinkedIn. Albert has been with the company since 2022 and previously served as a vice president.
Week of April 7
>Northern Light Health President and CEO Timothy Dentry announced plans to retire later this year.
He held the 10-hospital system's top role for the past five years, having come to the organization as chief operating officer in 2016. That time saw him at the helm during the COVID-19 pandemic and subsequent years' financial crunch. Northern Light Health's announcement also highlighted talent development initiatives and campus investments launched under his watch.
The announcement did not include a concrete date for Dentry's retirement. The Maine-based system said it is working with a national recruiting firm to select his successor.
Week of March 31
>AdventHealth has unveiled David Banks as its new president and CEO, effective immediately.
Banks has been with the 55-hospital health system for more than 30 years, and steps into the top spot from a role as CEO for its Primary Health Division and the Multi-State Division—in which he oversaw 22 campuses spanning eight states and three regional partnerships. He's also been the system's chief strategy officer for the past eight years.
The executive is taking over for Terry Shaw, who announced plans to retire after a 40-year stint with the health system. He will "continue to play an active role on the AdventHealth Board," the organization said at the time.
>NYU Langone Health has tapped Alec Kimmelman, M.D., as its next CEO and dean of the NYU Grossman School of Medicine.
He has been serving as director of the organization's Laura and Isaac Perlmutter Cancer Center since 2023, but has been with NYU Langone since 2016. Medical research takes up a large portion of his resume, with Kimmelman having published over 100 articles related to oncology, some of which have laid the groundwork for pancreatic cancer clinical trials.
The appointment takes effect Sept. 1 following the retirement of Robert Grossman, M.D., who headed the system for 18 years and had announced plans to retire last year. Grossman will take on a new role as executive vice president to the Board of Trustees.
>Ardent Health, a 30-hospital public, for-profit health system, has appointed Dave Caspers as chief operating officer. Caspers previously served as vice president of omnichannel operations at Walmart Health, had various leadership roles at Banner Health, and at one point led retail healthcare operations at Target.
Ardent also included in that announcement three promotions: Anika Gardenhire to chief digital and transformation officer, Rebecca Kirkham to senior vice president and chief communications and corporate affairs officer, and Reed Smith as senior vice president and chief consumer officer.
>GuideWell and insurer Florida Blue announced CEO Pet Geraghty will be stepping down at the end of the year. He held the role since 2011.
Week of March 24
>Providence Clinical Network (PCN), part of the Providence family of organizations, announced the appointment of Sam Bajaj as the new chief operating officer, effective March 31, 2025.
Bajaj brings over 17 years of extensive healthcare leadership experience across diverse care settings to PCN. "His strategic vision and operational excellence are poised to drive efficiency and innovation within our ambulatory care services, benefitting our patients, physicians, APPs, and caregivers alike," the organization said.
Most recently, Bajaj served as the COO of Optum California, where he managed a $7 billion P&L and held accountability for financial performance, growth, access, care quality, and patient experience. While at Optum, key areas of impact included teammate engagement and the integration of operations across six legacy care delivery organizations. Bajaj’s experience also includes significant leadership roles at Kaiser Permanente, where he oversaw hospital and health plan operations in the San Jose area, and his early career as a federal prosecutor at the United States Federal Trade Commission.
Week of March 17
> Cone Health, a nonprofit health system with four acute care hospitals and over 13,000 employees that's now part of Kaiser Permanente's Risant Health, announced President and CEO Mary Jo Cagle, M.D., will be departing the role "due to a serious family health matter," effective May 31.
Cagle was the system's first woman and first physician CEO, having been named to the role in 2021. Prior to that she held roles as chief operating officer and chief clinical officer with the organization.
Cone Health's announcement of Cagle's decision credited the physician-executive with prioritizing value-based care and navigating the COVID-19 pandemic.
“It has been a joy and privilege to lead this system. I’m incredibly proud of all we’ve accomplished to increase access to care, enhance patient safety and care quality,” Cagle said in the announcement. “The future is bright as Cone Health leverages new approaches, capabilities and data to make proactive wellness care affordable and accessible for all.”
While a nationwide search for Cagle's permanent replacement has been launched, Bernard Sherry will be serving as interim CEO starting June 1.
Sherry has been acting as the system's interim chief operating officer since December, with Cone Health noting that a permanent chief operating officer "is expected to be named in the weeks ahead." He has more than 30 years in senior leadership roles at community-based and multi-hospital systems, and most recently served as CEO and Ministry Market Executive for Ascension Wisconsin.
> Manatt Health, the legal and consulting healthcare group of Manatt, Phelps & Phillips, continues to add heavyweight talent to its team. Mandy Cohen, M.D., former director of the Centers for Disease Control and Prevention (CDC), and Vin Gupta, M.D., former Chief Medical Officer at Amazon Health, has joined the group. Cohen will serve as National Advisor and Gupta is serving as Managing Director.
Manatt said the addition of Cohen and Gupta will fortify the firm’s consulting and legal offerings for clients across state government, life sciences, digital health, health systems and health purchasers. The new hires also will grow Manatt’s capabilities in public health and strategic communication.
Cohen, also a former Secretary of Health and Human Services for North Carolina, brings her extensive government and health sector leadership experience to Manatt. "I want to continue affecting positive change and use everything I’ve learned over the course of my career to help make our world a healthier, safer place, especially as our clients navigate the new frontier of AI and changes at the federal and state levels,” she said in a statement.
Gupta, a public health leader and technologist who serves as a medical analyst for NBC News, will lead a diverse portfolio across health innovation at Manatt. “The collaboration, entrepreneurial spirit and focus on scaled impact made Manatt an ideal fit,” he said.
“Organizations across the spectrum of health are facing unprecedented challenges, which afford new opportunities for real change, whether it is in medical education, hospital-at-home or public health communications. The Manatt team is world class, and I am thrilled to get to work on helping to solve some of the country’s biggest problems in health care.”
> Foodsmart, a nutrition telehealth company, appointed Kurt Knight to the role of Chief Executive Officer. Previously Amwell’s COO, Knight built the company’s national provider group, managed all aspects of clinical operations and client delivery, and helped drive innovative partnerships with government, health systems, and national payers. He was instrumental in the acquisition and integration of four digital health companies, significantly strengthening the company's market position and expanding access to virtual care.
Knight will lead the company’s next phase of growth and his experience scaling Amwell’s digital health platform to serve millions of patients and over 100,000 providers will be key as Foodsmart grows its foodcare service, the company said.
Founder Jason Langheier, M.D. is transitioning to Chief Science Officer. "Through his thoughtfulness, sustained work ethic, and team-based approach, Kurt has been one of the key people that has fundamentally enabled the virtual care industry at scale. We are lucky to have a values-driven leader like Kurt – with a background in nutrition, and a shared vision for foodcare – bring his deep experience to our next phase of growth and impact,” Langheier said.
>Providence announced the appointment of Cherodeep (Chero) Goswami, as chief information officer. He will be starting his role on May 12.
>Qventus announced its appointment of Jeff Evans, former CEO and President of CAE Healthcare, as its Chief Commercial Officer following its $105 million Series D funding round in January, led by KKR .
> Culina Health, a virtual nutrition care company that partners with major insurers and Medicare to serve patients in all 50 states, will announce its appointment of Jane Mentz as Chief Operating Officer — marking a key milestone as the company’s first C-suite hire since its inception.
>TailorCare, a leader in specialty value-based care solutions, has appointed Steve Tutewohl as Chief Operating Officer.
>Neil Meltzer, president and CEO of LifeBridge Health, has announced his plan to retire following more than 12 years at the helm of one of Maryland’s leading health systems and more than 37 years of dedicated service to the organization. The LifeBridge Health Board of Directors is launching a national search for Meltzer’s successor to ensure a smooth leadership transition.
Week of March 10
> WellSpan Health promoted Patricia Donley, RN, DNP to the role of WellSpan senior vice president and chief nursing executive for the health system. In this role, Donley will oversee the integration of new models of nursing care and work to strengthen nursing innovation and research across the system, guiding key nursing initiatives to achieve sustainable advancements.
Donley has been a part of WellSpan for more than three decades, starting as a candy striper volunteer assisting nurses at WellSpan Good Samaritan Hospital in Lebanon. Over the years she rose through the ranks to most recently serving as hospital president, and system vice president. Prior to that, she served as vice president of patient care services and chief nursing officer for the hospital.
Week of March 3
> AdhereHealth, a company that works to improve medication adherence and value-based care solutions, restructured its C-suite. Kempton Presley has taken over as CEO. Patrick McNulty was appointed president and chief operating officer, and Chandra Osborn, Ph.D., was tapped as chief experience officer.
> Virtual applied behavioral analysis therapy provider AnswersNow has hired four industry leaders. Kristen Peterson will be vice president of clinical care delivery; Mason Davis will become senior vice president of K-12 partnerships; Tracey Sheahan is now head of revenue cycle management; and Wayne Li is vice president of care operations.
> Factor 7 Medical, a medtech commercialization advisory firm, has tapped five new hires: Justin Rowland as managing partner of sales and marketing; Brogan McGuire as managing partner of product development; Matt Otten as partner of regulatory and quality; Kim Frazier as partner of capital formation; and Michael Cooper as partner of product management and operations.
> Aaron Timm has been tapped as CEO of Openwater, the open-source medtech company delivering portable diagnostic and therapeutic devices at a fraction of typical costs.
> Healthcare cloud-based software company Inovalon has welcomed Adam Kansler as its new CEO.
> Wells Fargo Healthcare Banking announced it has promoted John Teasley to the newly created role of middle market segment market executive.